2011-2013
Subtheme 9.3: Program on Biosafety Systems (GRP 34)
Centers/ProgramsIFPRI
Target RegionsAsia, CWANA, LAC, SSA
Countries of Planned Research Potential Beneficiary Countries
 
Kenya, Malawi, Nigeria, Philippines, Uganda
 
Kenya, Malawi, Nigeria, Philippines, Uganda
CGIAR Priorities
1A - Conservation and characterization of staple crops
1B - Promoting conservation ands characterization of under-utilized plant genetic resources to increase the income of the poor
1C - Conservation of indigenous livestock
2C - Enhancing nutritional quality and safety
2D - Genetic enhancement of selected species to increase income generation by the poor
3A - Increasing income from fruit and vegetables
3B - Income increases from livestock
4D - Sustainable agro-ecological intensification in low- and high-potential environments
5A - Science and technology policies and institutions
5C - Rural institutions and their governance
5D - Improving research and development options to reduce rural poverty and vulnerability
Development Activities - Development Activities
Stand-alone Training - Stand-alone Training
Financing Sources
Members: Brazil, FAO, IDB, IDRC, IFAD, Japan, Sweden, United States, World Bank

Non Members: Agricultural Research Council, Bill and Melinda Gates Foundation, Confederacion Colombiana de Algodon, Ethiopia, IKP Trust, Mercy Corps, Others, OXFAM, Rutgers, The State University of New Jersey, Unres+Other Sources, Wageningen University
Project Overview and Rationale

The development of effective biosafety systems is important, both to encourage the growth of domestic agricultural R&D and to ensure safe access to new products and technologies developed elsewhere. The absence of a functional biosafety regulatory framework hinders public- and private-sector investment in agricultural development and makes products of modern agricultural research unavailable in a country.

Recent advances in agricultural applications of modern biotechnology, when properly applied, have a significant potential to contribute to sustainable gains in agricultural productivity and to reducing poverty and enhancing food security in developing regions. A growing body of literature exists documenting the farm-level benefits of genetically-modified (GM) plant varieties, such as introducing new traits providing enhanced resistance to diseases, potential tolerance to drought and soils contaminated with high concentrations of salt or heavy metals, and improved productivity. The potential for adverse environmental and human health consequences arising from the introduction of GM plants into agriculture has led to the development of regulatory regimes that are specifically applied to assessing the biosafety of these products. Developing countries face issues of how to foster a regulatory environment characterized by transparency and enabling innovation, and how to provide an effective system of accountability and stakeholder participation to build public confidence in decisionmaking.


Goal and Objectives

The purpose of the Program for Biosafety Systems (PBS) is to empower partner countries for science-based biosafety decisionmaking, while strengthening capacity to implement national biosafety systems.  The overall goal of the program is to more effectively address biosafety within a sustainable development strategy, anchored by agriculture-led economic growth, trade, and environment objectives. By the completion of the PBS program in 2013, it is intended that the following strategic outcomes will be accomplished:  

  1. A regulatory decisionmaking system that enables safe products to get to market is in place in partner countries in Africa and Asia that have demonstrated commitment to applying new biotechnologies in their food and agricultural sector.
  2. Partner countries with established regulatory systems have efficiently responded to emerging requirements resulting from international agreements or post-commercialization requirements.
  3. Robust regulatory approaches and risk analysis processes for biotechnology applications and commodity trade, based on commissioned scientific and policy research and regional consultations and collaboration with national and regional partners, have been incorporated into decisionmaking processes in target countries.
  4. Regulatory authorities and scientific institutions in target countries have conducted and implemented regulatory assessments, systematic stakeholder analyses, and timely decisionmaking on a pipeline of promising agricultural biotechnologies and traded commodities.


Project Outputs
Output Title
1: Regional and subregional models and initiatives for biosafety policies and procedures in Africa and Asia developed.
Output Description
Conduct, in collaboration with (sub-) regional organization:
  • Analysis of biosafety regulatory frameworks and options for regional collaboration
  • Regional policy consultations
  • Development of proposed regional guidelines
CGIAR Priorities
5A, 5B
Countries of Planned Research
n/a
Intended Users
Policymakers Biosafety regulators, national biosafety committees Representatives of regional policy and trade bodies Donor agencies Commercial entities and traders
Outcome
Regional exchange of biosafety data, guidelines and templates GM biosafety decisions endorsed by neighboring countries Regulatory systems more efficient in terms of procedures and costs Improved enabling environment for trade in GM varieties
Impact
Accelerated review and, where relevant, introduction of new technologies that contribute to sustainable gains in agricultural productivity, reductions in poverty, enhanced food security and nutritional status."

Output Target
Year Target Type Target Description
2011
Policy strategies
Common guidelines and templates by subregional trade and policy bodies completed: APEC
2011
Policy strategies
Common guidelines and templates by subregional trade and policy bodies completed: COMESA

Output Title
2: Research, new knowledge, and information for biosafety policy development and regulatory decisionmaking.
Output Description
Policy analysis and outreach related to:
  • Trade implications of biosafety regulations
  • Incorporating socioeconomic considerations
  • Emerging legal requirements such as liability
CGIAR Priorities
5A, 5B
Countries of Planned Research
n/a
Intended Users
Policymakers Biosafety regulators, national biosafety committees Representatives of regional policy and trade bodies Donor agencies Private sector
Outcome
Enhanced understanding of social and economic implications of GM policy options and alternatives Regulatory systems more efficient in terms of procedures and costs Evidence-based biosafety policies adopted Comparative analyses of regulatory systems
Impact
Accelerated review and, where relevant, introduction of new technologies that contribute to sustainable gains in agricultural productivity, reductions in poverty, enhanced food security and nutritional status."

Output Target
Year Target Type Target Description
2011
Policy strategies
Policy compendiums and papers analyzing country experiences, policy options, stakeholder mapping, and best practices.
2011
Policy strategies
Science-based policies, biosafety strategies and procedures for confined GMO releases implemented in PBS partner countries: Malawi, Nigeria, Vietnam.
2011
Policy strategies
Science-based policies, biosafety strategies and regulatory procedures for general GMO releases implemented in PBS partner countries: Kenya, Uganda, and Philippines.

Output Title
3: Enabling environment enhanced for confined field trials and general releases, emphasizing a risk management approach.
Output Description
Technical assistance and guidance to:
  • Development of enabling guidelines and operating procedures
  • Regulatory agencies considering field trial applications and general releases
  • Applicants developing biosafety dossiers
CGIAR Priorities
Countries of Planned Research
Kenya, Malawi, Nigeria, Philippines, Uganda
Intended Users
Biosafety regulators, national and institutional biosafety committees Implementing agencies, e.g. plant quarantine offices, plant variety offices, food safety agencies  Public R&D organizations, universities, private sector
Outcome
Practical and science-based implementing regulations and operating procedures adopted Applications for field trials submitted, and reviewed by competent authorities.
Impact
Product development progress for adoption of publicly-developed GM products relevant to small-scale farming systems that contribute to sustainable gains in agricultural productivity, reductions in poverty, enhanced food security and nutritional status."

Output Target
Year Target Type Target Description
2011
Practices
Confined field trials completed in PBS partner countries: Kenya, Malawi, Nigeria, Uganda, Vietnam, and Philippines.
2011
Practices
Implementing regulations for general releases adopted in PBS partner countries: Kenya, Uganda

Output Title
4: Capacity and skills for biosafety/food safety risk assessment, risk management and stakeholder mapping enhanced.
Output Description
Capacity and skills development through:
  • Supporting environmental risk assessment research (competitive grants)
  • Technical advice and assistance
  • On-the-job training and workshops
CGIAR Priorities
5A, 5B, 5C, 5D
Countries of Planned Research
Kenya, Malawi, Nigeria, Philippines, Uganda
Intended Users
Public R&D organizations Universities Biosafety regulators, and national biosafety committees Policymakers Donor agencies
Outcome
Strengthened science base for biosafety assessments Strengthened review and decisionmaking skills and confidence among regulators, policymakers, and scientists Strengthened skills in stakeholder analysis to guide policy development, implementation, and communication
Impact
Improved policies, communication, and decisionmaking procedures based on local science and local analyses Safe use of biotechnology and GM products in partner countries that contribute to sustainable gains in agricultural productivity and to reducing poverty and enhancing food security "

Output Target
Year Target Type Target Description
2010
Capacity
Enhanced skills for biosafety/food safety risk assessment and risk management among regulatory decisionmakers: Kenya, Malawi, Nigeria, Uganda, the Philippines.
2010
Capacity
Local research capacity expanded to undertake biosafety/food safety risk assessment and risk management through competitive grants: the Philippines.
2011
Capacity
Enhanced competency among regulatory decisionmakers, research institutions, and policymakers to conduct stakeholder assessments related to biotechnology product development and deployment.
2011
Capacity
Enhanced competency and efficiency among regulatory agencies: Kenya, Malawi, Nigeria, Uganda, Philippines, Vietnam.
2011
Capacity
Enhanced skills for biosafety/food safety risk assessment and risk management among regulatory decisionmakers: Kenya, Malawi, Nigeria, Uganda, Philippines, Vietnam.
2012
Capacity
Enhanced competency and efficiency among regulatory agencies: Malawi, Nigeria.
2012
Capacity
Enhanced skills for biosafety/food safety risk assessment and risk management among regulatory decisionmakers.

Note: Financial Tables, Target Regions, CGIAR Priorities and Financing Sources show aggregated data for more than one MTP project and in particular for: - Subtheme 9.1: Genetic Resource Policies for the Poor (GRP 1) - Subtheme 9.2: Agricultural Science, Technology and Innovation Policy (GRP 31) - Subtheme 9.3: Program on Biosafety Systems (GRP 34)


Allocation of Member, Non-Member Grants and other sources to projects, 2009-2011
in $millions

Project Member Actual
2009
Estimated
2010
Proposal
2011
Project Total
6.841
7.879
7.706
Theme 9: Science and TechnologyMemberBrazil
0.003
0.004
0.000
FAO
0.000
0.002
0.000
IDB
0.040
0.000
0.000
IDRC
0.057
0.075
0.087
IFAD
0.061
0.000
0.000
Japan
0.045
0.000
0.000
Sweden
0.046
0.000
0.000
United States
3.842
3.623
3.496
World Bank
0.000
0.085
0.069
Non MemberAgricultural Research Council
0.104
0.165
0.192
Bill and Melinda Gates Foundation
0.858
0.988
1.172
Confederacion Colombiana de Algodon
0.008
0.000
0.000
Ethiopia
0.019
0.076
0.000
IKP Trust
0.036
0.202
0.250
Mercy Corps
0.029
0.096
0.092
Others
0.158
0.257
0.204
OXFAM
0.007
0.045
0.003
Rutgers, The State University of New Jersey
0.038
0.047
0.066
Wageningen University
0.029
0.000
0.000
Unres+Other SourcesUnres+Other Sources
1.461
2.214
2.075


Allocation of Project Costs to CGIAR Priorities, 2009-2013
in $millions

Project Actual
2009
Estimated
2010
Proposal
2011
Plan 1
2012
Plan 2
2013
Priorities
Theme 9: Science and Technology
Project Total
6.841
7.879
7.706
8.015
8.336
1A
0.918
1.058
1.034
1.077
1.120
1B
0.019
0.022
0.022
0.022
0.023
1C
0.019
0.022
0.022
0.022
0.023
2C
0.451
0.520
0.509
0.529
0.550
2D
0.575
0.662
0.647
0.673
0.700
3A
0.441
0.507
0.496
0.516
0.537
3B
0.038
0.044
0.043
0.045
0.047
4D
0.616
0.709
0.694
0.721
0.750
5A
1.683
1.938
1.896
1.973
2.052
5C
0.757
0.872
0.853
0.887
0.923
5D
0.365
0.420
0.411
0.427
0.444
Development Activities
0.480
0.553
0.540
0.562
0.584
Stand-alone Training
0.479
0.552
0.539
0.561
0.583


Project investment by developing Region, 2009-2013
in $millions

Project Target Regions Actual
2009
Estimated
2010
Proposal
2011
Plan 1
2012
Plan 2
2013
Project Total
6.841
7.879
7.706
8.015
8.336
Theme 9: Science and TechnologyAsia
1.043
1.528
1.865
1.940
2.018
CWANA
0.000
0.188
0.000
0.000
0.000
LAC
0.401
0.675
0.340
0.354
0.368
SSA
5.397
5.488
5.501
5.721
5.950